News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Changes in Healthcare Costs During the Obama Administration: Government Spending

A look at the numbers resulting from healthcare reform and the Affordable Care Act across the eight years of the Obama Administration

Over the eight years of the Obama administration, there has been significant and unprecedented legislation intended to address the well-known problems with health insurance and high healthcare costs in this country. There has also been plenty of bluster, criticism, and commentary about the consequences of the Affordable Care Act (ACA), which became law in 2010.

With a new administration and Congress about to take office, many media outlets and experts are looking back over the past eight years to assess what actually happened to the US healthcare system during this time. From independent medical laboratories and pathology groups, to large-scale health systems, reform and the impact of the Obama Administration has changed—and continues to change—the way America approaches healthcare.

Over President Obama’s two terms, there were significant changes to payment structures, insurance markets, and communications between healthcare service providers. In turn, these initiatives have spurred innovation and drastically altered the way many healthcare and diagnostics providers operate. (more…)

McKinsey Reports That Consumers Will Find Fewer Options under the ACA in 2017 while Fewer Health Plans Means Less Access for Clinical Laboratories

Local medical labs and pathology groups are often excluded from narrow networks. Thus, another round of “network provider reduction” is a serious issue

Total enrollment in health insurance products may be increasing, but in its recently-issued study, McKinsey and Company determined that the Health Insurance Marketplace (Health Exchange) is shrinking even as the number of enrollees continues to rise.

The development is unfavorable to the nation’s clinical laboratories and pathology groups because fewer health plans on the exchange means less access to patients. It also means that the remaining health insurers are taking steps to further narrow their existing networks in order to curb expenses by limiting options.

The new report published by McKinsey and Company reveals that insurers are moving towards plans that offer fewer options for consumers, mostly due to losses suffered on the health exchanges. The report, titled, “2017 Exchange Market: Plan Type Trends,” states that in 2017 a majority of the healthcare plans (about 75%) available to consumers under the Affordable Care Act (ACA) will be Health Maintenance Organizations (HMOs) and other similar limited-option plans, such as Exclusive Provider Organizations (EPOs).

EPOs are a hybrid of HMOs and PPOs and share some common options from both. Of the states investigated, McKinsey found that about 15% of customers eligible for ACA exchanges will have no PPOs available to them. (more…)

Kaiser Family Foundation Study Predicts Big Increases in Obamacare Premiums for 2017; However, Narrow Networks Often Exclude Clinical Laboratories and Other Providers

Accountable Care Act has reduced the number of uninsured, but has failed to deliver lower costs for most Americans or employers

More big increases are coming to Obamacare premiums during 2017. This is an important development and, depending on how the new Congress decides to address problems with the Affordable Care Act (ACA), the consequences can be either positive or negative for clinical laboratories and anatomic pathology groups.

Large increases in healthcare premiums can have a trickle-down effect on clinical laboratories and pathology groups since health insurers tend to reduce reimbursements to providers when they are in a financial squeeze. And while the November election puts the future of the ACA in doubt, a recently released Kaiser Family Foundation (KFF) study adds further evidence that Obamacare (colloquial for the ACA) has fallen short of its goal of reining in healthcare costs while simultaneously expanding healthcare coverage to millions of Americans.

The KFF study shows premiums in the ACA’s Health Insurance Marketplace will continue to increase in many regions in 2017. Researchers blame the higher price in part to the phasing out of the ACA’s reinsurance program and the unexpected losses many participating insurers have experienced. (more…)

More Small and Midsize Companies Opt to Self-Fund Workers’ Health Plans Despite Potential Risks: Might Clinical Labs Benefit from This Trend?

Self-insurance trend could push more businesses to independent and local clinical laboratories if self-insurers prefer to offer employees local access to testing services

Three years after the roll out of the Affordable Care Act’s (ACA’s) major provisions, more small and midsize companies may be opting to self-insure their employee health plans rather than face the coverage mandates and administrative costs imposed by Obamacare, a recent study found. It is uncertain how this trend will improve the access clinical laboratories and pathology groups have with these patients.

The Employee Benefit Research Institute (EBRI) study looked at trends in private sector self-insured health plans between 1996-2015, with a focus on 2013-2015, to assess whether the ACA might have affected those trends.

Researchers analyzed survey data from nearly 40,000 employers that participated in the US Census Bureau’s Medical Expenditure Panel Survey Insurance/Employer Component. They found that from 2013 to 2015: (more…)

CPC+ Continues CMS’ Efforts to Establish Medical Homes

The trend toward alternative payment systems continues as CMS announces the Comprehensive Primary Care Plus (CPC+) model

Efforts by Medicare officials to move providers away from fee-for-service payments and onto other models of reimbursement continue to move forward. This is one of several goals for a new primary care program that Medicare is about to launch in coming months.

Medical laboratories and pathology groups might feel an impact from this new program the Centers for Medicare and Medicaid Services (CMS) is testing. Announced in April, 2016, the program is called Comprehensive Primary Care Plus (CPC+). The CPC+ program is a five-year model that is designed to strengthen primary care, through establishing what are called “medical homes,” where patients experience more coordinated care. (more…)

;